We are live on ! Find out more
ATYR

aTyr Pharma
ATYR

35 hedge funds and large institutions have $51.3M invested in aTyr Pharma in 2018 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 10 increasing their positions, 6 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 6

0.41% more ownership

Funds ownership: 4.21% → 4.62% (+0.41%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

15% less funds holding

Funds holding: 41 → 35 (-6)

16% less capital invested

Capital invested by funds: $61.3M → $51.3M (-$10.1M)

86% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 7

Holders
35
Holders Change
-6
Holders Change %
-14.63%
% of All Funds
0.8%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
1
Increased
10
Reduced
6
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$602K
2
Renaissance Technologies
Renaissance Technologies
New York
+$364K
3
Deutsche Bank
Deutsche Bank
Germany
+$176K
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$96.1K
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$92.4K

Top Sellers

Rank Fund Capital Flow
1
RSCM
Rock Springs Capital Management
Maryland
-$1.66M
2
JP Morgan Chase
JP Morgan Chase
New York
-$105K
3
Millennium Management
Millennium Management
New York
-$76K
4
Citadel Advisors
Citadel Advisors
Florida
-$45K
5
Morgan Stanley
Morgan Stanley
New York
-$29.3K
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$11.9M +$60.7K +1,295 +0.4%
EC
2
EcoR1 Capital
California
$10.6M – – –
RG
3
Redmile Group
California
$5M -$6.05K -129 -0.1%
SI
4
Sofinnova Investments
California
$4.95M +$6.25M +133,295 New
PVMCV
5
Polaris Venture Management Co V
Massachusetts
$4.84M – – –
Viking Global Investors
6
Viking Global Investors
Connecticut
$3.67M – – –
Alyeska Investment Group
7
Alyeska Investment Group
Illinois
$1.85M -$21K -449 -0.9%
Vanguard Group
8
Vanguard Group
Pennsylvania
$1.77M +$602K +12,852 +37%
AG
9
Artal Group
Luxembourg
$1.32M – – –
Renaissance Technologies
10
Renaissance Technologies
New York
$1.03M +$364K +7,764 +39%
BlackRock
11
BlackRock
New York
$1.02M +$61.9K +1,320 +5%
GHCM
12
Glen Harbor Capital Management
California
$406K – – –
MCIM
13
Meadow Creek Investment Management
Georgia
$334K – – –
Dimensional Fund Advisors
14
Dimensional Fund Advisors
Texas
$303K +$96.1K +2,050 +33%
Deutsche Bank
15
Deutsche Bank
Germany
$290K +$176K +3,758 +92%
Geode Capital Management
16
Geode Capital Management
Massachusetts
$280K – – –
BCM
17
Bridgeway Capital Management
Texas
$272K – – –
EP
18
Elkfork Partners
Oregon
$263K – – –
RCM
19
Riverhead Capital Management
Delaware
$211K – – –
TAM
20
Tyers Asset Management
Texas
$191K – – –
Connor, Clark & Lunn Investment Management (CC&L)
21
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$117K – – –
Bank of America
22
Bank of America
North Carolina
$111K – – –
Acadian Asset Management
23
Acadian Asset Management
Massachusetts
$88K +$92.4K +1,972 +468%
Northern Trust
24
Northern Trust
Illinois
$80K -$11.4K -243 -10%
Jacobs Levy Equity Management
25
Jacobs Levy Equity Management
New Jersey
$75K -$28.4K -607 -23%
1
2

ATYR Hedge Fund Activity: Q1 2018 in Review

35 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in aTyr Pharma (ATYR) for Q1 2018, worth a combined $51.3M — down 16% from $61.3M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of ATYR and 1 opened new positions — a net loss of 6 holders — while 6 trimmed existing stakes and 10 added.

The largest buyer was Vanguard Group, adding an estimated $602K. The largest seller was Rock Springs Capital Management, exiting entirely with an estimated $1.66M sold.

  • 35 institutional investors held aTyr Pharma (ATYR) as of Q1 2018, down from 41 in Q4 2017.
  • Funds reported $51.3M of aTyr Pharma stock for Q1 2018, down 16% quarter-over-quarter.
  • 1 fund opened new aTyr Pharma positions in Q1 2018 and 7 closed out, a net change of -6 holders.
  • The largest aTyr Pharma buyer in Q1 2018 was Vanguard Group, an estimated $602K added.
  • The largest aTyr Pharma seller in Q1 2018 was Rock Springs Capital Management, an estimated $1.66M sold.

Based on aggregated 13F filings for Q1 2018.